Royalty Pharma Plc (RPRX)
38.64
-0.35
(-0.90%)
USD |
NASDAQ |
Dec 31, 16:00
38.63
-0.01
(-0.03%)
Pre-Market: 08:28
Royalty Pharma Shareholders Equity (Quarterly): 6.414B for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Denali Therapeutics, Inc. | 926.20M |
| Alnylam Pharmaceuticals, Inc. | 233.89M |
| Amgen, Inc. | 9.619B |
| Eli Lilly & Co. | 23.79B |
| Zenas BioPharma, Inc. | 196.43M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 19.35B |
| Total Liabilities (Quarterly) | 9.726B |
| Debt to Equity Ratio | 1.397 |
| Current Ratio | 3.484 |
| Net Debt Paydown Yield | -1.80% |